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The use of phages is an attractive option to battle antibiotic resistant bacteria in certain bacterial infections, but the role of
phage ecology in bacterial infections is obscure. Here we surveyed the phage ecology in septicemia, the most severe type of
bacterial infection. We observed that the majority of the bacterial isolates from septicemia patients spontaneously secreted
phages active against other isolates of the same bacterial strain, but not to the strain causing the disease. Such phages were
also detected in the initial blood cultures, indicating that phages are circulating in the blood at the onset of sepsis. The fact
that most of the septicemic bacterial isolates carry functional prophages suggests an active role of phages in bacterial
infections. Apparently, prophages present in sepsis-causing bacterial clones play a role in clonal selection during bacterial
invasion.
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INTRODUCTION
Septicemia is a serious medical condition where bacteria present in
the blood circulatory system provoke an amplified and dysregu-
lated immune response in the individual. The most common
infection sites leading to bacterial entry into the circulatory system
are bacterial infections in the lungs, urinary tract, abdominal
cavity, and primary infections of the bloodstream [1]. Rapid
antibiotic intervention is currently the only way to treat septicemia
(as well as other bacterial infections). However, many bacterial
pathogens have become resistant to antibiotic regimens, resulting
in an urgent health problem worldwide [2,3]. One potentially
useful method for the treatment of antibiotic resistant bacterial
infections employs bacterial viruses called bacteriophages (also
known as phages) capable of killing bacteria [4–7]. They were
widely used to treat bacterial infections since their discovery in the
beginning of the twentieth century, but their use was neglected in
western countries after the discovery of antibiotics [6,8]. The
modern application of phages in parts of the world that require
documented and scientifically controlled clinical experiments is
limited to the protection of ready-to-eat meat and poultry products
[9]. Phage derived enzymes lytic to Gram-positive bacteria are the
most promising candidates to enter the markets for therapeutic use
[10,11].
In contrast to virulent phages, which kill bacteria immediately,
temperate phages integrate their genomes into bacterial chromo-
somes to establish a prophage state. Prophages and other genetic
elements such as transposons, plasmids, and pathogenicity islands
encode virulence factors [12]. Temperate phages disseminate
virulence genes and thus contribute to the evolution and
emergence of new pathogenic bacteria. Only the most virulent
bacterial clones are capable of tissue invasion possibly leading to
septicemia, as the bacteria have to overcome anatomical and host
immune system barriers to enter the circulatory system. Although
there is considerable information regarding prophages [13,14] and
phage-encoded virulence factors in bacterial pathogens [15], few
studies have investigated microbial ecology in clinical bacterial
infections. Here we surveyed the phage ecology in septicemia, the
most severe type of bacterial infection. We observed that the
majority of septicemia-causing bacteria could be induced to
produce phages active against other isolates of the same bacterial
strain. Such phages were also detected in the initial blood cultures,
indicating that phages are circulating in the blood at the onset of
sepsis. Further characterization of the phage isolates revealed that
the virus detected in the blood culture was the same as induced
from the bacterium isolated from that particular blood culture
sample.
RESULTS
The Majority of Septicemia-Causing Bacteria Can Be
Induced to Produce Phages
In this report we investigated Escherichia coli (Ec), Pseudomonas
aeruginosa (Pa), Staphylococcus aureus (Sa) and Klebsiella pneumoniae (Kp)
isolates from septicemia patients. Two sets of bacterial isolates and
blood culture samples were obtained (Set I 150 and Set II 30
bacterial isolates, Table S1). Set I samples were analyzed by
plating the blood culture sample (stored at –80uC) with the
homologous bacterial strain. (Homologous strain refers to the
strain originally isolated from that particular blood culture sample.
Heterologous strains are other bacterial strains isolated from blood
culture samples or elsewhere.) None of the blood culture samples
contained plaque-producing viruses, indicating that no virulent
phages were present. However, eight Pa strains produced plaques
when plated without the blood culture sample (10
2–10
4 PFU/ml)
(Table S1). These strains were likely lysogens that spontaneously
released viruses and were sensitive to their own viruses. This result
suggested that prophages resided in the bacterial isolates. Ten
randomly selected heterologous strains from Set I and elsewhere
were then used as indicators to test for spontaneous phage
induction. Prophages were also induced with UV and mitomycin
C (MitC) under conditions that reduced the host cell viability by
several orders of magnitude. Mid-logarithmic cell culture super-
natants were then probed for phage induction by plaque assay.
Academic Editor: Floyd Romesberg, The Scripps Research Institute, United States
of America
Received July 16, 2007; Accepted October 16, 2007; Published November 7, 2007
Copyright:  2007 Gaidelyte ˙ et al. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Funding: This work was supported by the Academy of Finland Finnish Centre of
Excellence Programme 2006-2011 (grants 1210253, 1213992, 1213467 to DHB).
Competing Interests: The authors have declared that no competing interests
exist.
* To whom correspondence should be addressed. E-mail: dennis.bamford@
helsinki.fi
PLoS ONE | www.plosone.org 1 November 2007 | Issue 11 | e1145Phages were detected in 91 out of 150 culture supernatants
(Table 1) ranging from 10 to 10
7 PFU/ml. Plaques appeared only
on one indicator strain in about half of the cases, suggesting that
a larger indicator set could result in the detection of more phage-
producing strains. Three virus-producing clones were tested for
the type of phage or phages released for all four bacterial strains
using the sensitivity pattern of the indicator strains. Only a single
pattern was detected in most of the test cases. These data indicate
that the bacterial clones released one or only a few types of phages.
We next tested if antibiotics commonly used to treat septicemic
infections could induce plaque formation in clinical bacterial
isolates. We selected five strains (3 Ec and 2 Sa) that did not
produce plaques spontaneously but did so after treatment with
MitC or UV, to test this idea. Indicator strains (one indicator
strain per bacterial isolate) were selected based on data from the
experiment described above. We did not observe plaque formation
when the cells were treated with tobramycin. However, cipro-
floxacin induced phage release from one of the Sa strains. It has
been shown previously that ciprofloxacin treatment causes
prophage induction (and virulence modulation) in S. aureus from
patients with cystic fibrosis [16] as well as in shiga-toxin producing
E. coli strains of human origin [17–19]. In some cases, like
infections with enterohemorrhagic E. coli O157:H7, antibiotic
treatment is controversial because of prophage induction, in-
creasing the risk of the hemolytic-uremic syndrome [18,20].
Selected Phage-Sensitive Septicemia-Causing Hosts
Allowed to Detect High Virus Titers in Original Blood
Culture Samples
Results described above indicate that most (if not all) of the
bacteria studied here are lysogenic, suggesting that there should be
phages present in the original blood culture samples due to
spontaneous or induced induction. Using the indicator bacterial
strains identified in the lysogeny screening, blood culture samples
from Set I (Table S1) were subjected to plaque assay. Plaques were
detected in 10 of the 149 samples (,7%, Table 2). This assay was
performed several months after the blood collection and the
samples had been frozen and thawed. Freezing has an adverse
effect on the virus viability. To eliminate this discrepancy we
collected another set of samples (Set II, n=30) and screened them
for possible plaque-forming phages two days after sample
collection (Table S1). We also increased the number of possible
indicator strains used in the analyses. We observed plaque
formation in 10 of the 30 (33%) blood culture samples, with titers
ranging from 10 to 10
6 PFU/ml (Table 3). In most cases when
phages were detected in the blood culture samples the correspond-
ing bacterial isolate spontaneously released phages capable of
infecting the same indicator strain (Table S1).
The Virus Induced from a Septicemic Bacterium Is
Always the Same as Detected in the Original Blood
Culture Sample
Attempts to grow the isolated phages to high titer and to purify
them using polyethylene glycol precipitation and rate zonal
sucrose gradient centrifugation succeeded in 36 cases (24 from
Set I and 12 from Set II, Table S2). Phage morphology was
determined by negative staining electron microscopy, and the
virion structural protein pattern was determined by electrophoresis
(SDS-PAGE). Thirty-four of the phages showed a typical tailed
dsDNA phage morphology characteristic of myo-, sipho-, or
podoviruses, with a head diameter often about 50 nm. Two of the
phage isolates were filamentous. We did not detect any other
morphotypes. For eleven of the samples both the blood culture
Table 1. Number of Set I bacterial isolates producing
spontaneous or induced plaques.
......................................................................
Bacteria Spontaneous MitC UV Total unique /all isolates
E. coli 25 40 45 57/90
S. aureus 7 13 8 16/26
P. aeruginosa 16 16 15 16/16
K. pneumoniae 2 2 2 2/18
Total: 91/150
doi:10.1371/journal.pone.0001145.t001
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Table 2. Phage titer of Set I blood culture samples detected
on selected indicator strains.
......................................................................
Blood culture sample (Set I) Indicator strain Titer (PFU/ml)
E. coli (6/90) ,7%
05vv1387 Ec1457 2610
4
05vv1522 YMC 1610
5
05vv1558 Ec1522 2610
3
05vv1809 YMC 2610
2
05vv1999 Ec2424 1610
2
05vv2388 Ec1643 2610
3
S. aureus (0/26) 0%
P. aeruginosa (3/16) ,19%
05vv1315 Pa1400 6610
3
05vv1400 Pa1414 2610
3
05vv1973 Pa1651 5610
4
K. pneumoniae (1/18) ,6%
05vv2343 Kp1752 1610
4
doi:10.1371/journal.pone.0001145.t002
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Table 3. Phage titer of Set II blood culture samples detected
on indicator strains with the best efficiency of plating.
......................................................................
Blood culture sample (Set II) Indicator strain Titer (PFU/ml)
E. coli (4/14) ,29%
06vv2974n Ec1457 ,2610
3
06vv2987a YMC 2610
4
06vv3183n Ec1522 1.4610
6
06vv3242 Ec1522 1610
5
S. aureus (5/12) ,42%
06vv2986a Sa1912 ,4610
3
06vv3106a Sa1912 10
1
06vv3133n Sa1912 4610
1
06vv3189n Sa1912 3610
5
06vv3244 Sa1263 1610
3
P. aeruginosa (0/3) 0%
K. pneumoniae (1/1) 100%
06VT145a Kp1752 2610
3
doi:10.1371/journal.pone.0001145.t003
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lysogenic bacterium were recovered (designated as a phage pair).
Interestingly, the pairs were always identical when the morphol-
ogies and structural protein patterns of these phage pairs were
analyzed (Figure 1). We also detected identical (based on structural
protein patterns) phage isolates (not pairs) from the blood culture
samples or induced from lysogenic bacteria. The highest number
(seven) of identical isolates was detected from Ec. All these isolates
infected the same bacterial strain (YMC). Likewise, the two
filamentous Pa phages had the same structural protein pattern and
morphology. These data indicated that common phage strains
were circulating in this hospital setting.
DISCUSSION
Many bacterial genomes carry both defective and functional
prophages [13,14]. These greatly contribute to the bacterial
phenotype and can alter important biological properties.
Bacterial cells carrying prophages usually are immune to the
infection of the same phage type. Interestingly, we observed that
eight auto-induced Pa phages and two staphylococcal phages
(Phi05_1554 and Phi05_1912a) infected their homologous hosts.
When several potential heterologous hosts (of the same bacterial
strain) were used, a spontaneous or induced phage production was
detected in 95 out of 180 isolates. Since more phages were detected
when the indicator test set was increased, it is possible that the
observed inducible phages (and lysogenic bacteria) represent only
a minimal estimate of the actual total. Similarly, the number of
phages detected in the blood culture samples is also likely a minimal
estimate because of virus decay and possible suboptimal indicator
host usage. The observation that the induced phages were
consistently identical to those found in the homologous blood
culture sample indicates that there are both bacteria and phages
circulating in the blood of septicemic patients. The fact that most of
the sepsis-causing bacteria carry functional prophages suggests an
active role of phages in bacterial infections. Phages released from
majority of septicemic bacterial isolates are active against other
isolates of the same bacterial strain, but not to the strain causing the
disease. Apparently, prophages present in sepsis-causing bacterial
clones play a role in clonal selection during bacterial invasion. A
similar concept has been proposed for Streptococcus pneumoniae isolated
from the nasopharynx [21]. Prophage MM1 improves bacterial
adherence to the surface of pharyngeal cells and thus contributes to
thepathogenfitnessanditspersistenceinhumans.Itisalsolikelythat
bacteriocins are induced from sepsis-causing bacteria. Our pre-
liminarystudiesonthefilamentousPaphagesisolatedhereshowthat
large amounts of pyocins (Pa bacteriocins) are released upon phage
production. Obviously a complex ecosystem is generated in
septicemia where the human immune system and bacteria, phages
and possibly bacteriocins operate simultaneously with fatal con-
sequences to the infected individual.
The observations made here support the idea that viruses are
found in practically all ecological niches, including bacterial
infections. Therefore, the therapeutic use of phages in septicemic
patients relies on the understanding of the ecosystem created by
the patient, pathogenic bacteria, phages, and possible bacteriocins.
MATERIALS AND METHODS
Study design
The samples used in this study consisted of E. coli, K. pneumoniae, S.
aureus and P. aeruginosa strains originating from septicemic patients
isolated from consecutive blood cultures taken from those patients.
They also consisted of fluid samples taken from the corresponding
blood cultures. Only one sample per patient was included to
Figure 1. Characterization of phage isolates grown to high titers. Upper panel, electron micrographs of negatively stained phage preparations. Bar,
100 nm. Lower panel, SDS-PAGE analysis of the same phage preparations. The first and last lanes of the gel contain protein size standards (BioRad).
Molecular weights of protein standards are indicated on the left.
doi:10.1371/journal.pone.0001145.g001
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data were removed from all material related to the study to protect
the anonymity of the patients. According to ethical principles stated
in the Declaration of Helsinki this survey did not involve identifiable
humanmaterialoridentifiablepatientdataandthusethicalapproval
was not deemed necessary. Isolates and blood culture samples were
collected in the Helsinki University Hospital laboratory during two
time periods (April 27 through August 5, 2005 and August 29
through September 25, 2006). During the first time period, 149
blood culture samples and 150 bacterial strains were collected and
frozen at –80uC until use (Set I). During the second time period 30
blood culture samples and 30 bacterial isolates were obtained and
processed immediately (Set II). Three different specimens with the
same origin were marked with the same four-digit number: blood
sample (05vv or 06vv), bacterial isolate (Ec for E. coli,S af o rS. aureus,
Pa for P. aeruginosa,o rK pf o rK. pneumoniae), and phage (Phi).
Common laboratory strains including E. coli K12 YMC, P. aeruginosa
K, O5(R18), O(pJB10), O1(pLM2), and O were also used. Bacteria
were cultivated in Luria-Bertani broth (LB) at 37uC with aeration.
Cell density was measured using a Klett colorimeter (A540)
manufactured by Bel-Art Products.
Phage quantitation
To quantitate virulent phages in blood culture samples, the sample
was cleared by centrifugation for five min at 13,000 rpm at 22uC
(Heraeus Biofuge) and plated with a suspension of the bacterium
originally isolated from that sample (homologous bacterium). To
quantitate temperate phages, cleared blood culture samples were
diluted up to 100-fold and plated with selected indicator strains
(see below). To detect spontaneous phages in culture supernatants
of bacteria originally isolated from blood culture samples, bacterial
isolates were grown to 200 Klett units at 37uC with aeration,
sedimented by centrifugation for five min at 13,000 rpm at 22uC
(Heraeus Biofuge), and serial 10-fold dilutions of supernatants
were plated with selected indicator strains.
Selected potential indicator strains for Set I
For E. coli, Ec1255, Ec1457, Ec1522, Ec1643, Ec1685, Ec1758,
Ec1809, Ec1910, Ec2311, Ec2424, and YMC were used as potential
indicator strains. For S. aureus, Sa1252, Sa1303, Sa1433, Sa1469,
Sa1582, Sa1631, Sa1742, Sa1808, Sa1896, Sa2320, and Sa1987
were used as potential indicator strains. For P. aeruginosa, Pa1315,
Pa1400, Pa1414, Pa1499, Pa1641, Pa1651, Pa1786, Pa2302,
Pa2371, K, O5(R18), O(pJB10), O1(pLM2), and O were used as
potential indicator strains. For K. pneumoniae, Kp1447, Kp1468,
Kp1473, Kp1586, Kp1627, Kp1752, Kp1823, Kp1897, Kp2329,
Kp2362, and Kp2385 were used as potential indicator strains.
Selected potential indicator strains for Set II
Cleared blood culture samples infected with E. coli from Set II
were plated with the following 25 strains: Ec1255, Ec1321,
Ec1457, Ec1507, Ec1522, Ec1572, Ec1643, Ec1675, Ec1685,
Ec1748, Ec1758, Ec1798, Ec1809, Ec1816, Ec1905, Ec1910,
Ec1998, Ec1999, Ec2000, Ec2311, Ec2392, Ec2400, Ec2407,
Ec2424, and YMC. Samples infected with S. aureus or K. pneumoniae
were plated with all S. aureus or K. pneumoniae strains from Set I (see
Table 1), respectively. Samples infected with P. aeruginosa were
plated with the following strains: Pa1315, Pa1400, Pa1414,
Pa1641, Pa1651, Pa1786, Pa2302, Pa2371, O5(R18), and K.
Spontaneous plaque production by Set II bacterial isolates was
tested using the same indicator strains as listed for Set I except that
some additional strains were verified based on results obtained
with blood culture samples.
Phage induction
For UV induction, bacteria were grown to 200 Klett units and
collected by centrifugation for 10 min at 6,000 rpm using a Sorvall
SS-34 rotor at 4uC. Bacteria were suspended in the same volume
of M9-broth and transferred to a glass Petri dish. The bacterial
suspension was irradiated for 42 sec at A254 followed by dark
storage on ice for 1 h. Cells were collected by centrifugation for
5 min at 13,000 rpm using a Heraeus Biofuge at 22uC. Bacteria
were suspended in 3 volumes of LB and the number of plaques
was determined after additional two h incubation at 37uC.
For MitC induction experiments, cells were grown to 200 Klett
units and induced with MitC at a final concentration of 5 mg/ml.
Cells were incubated for 15 min at 37uC and the growth medium
was then replaced with fresh LB. Plaques were determined after
additional two h incubation at 37uC.
To test if antibiotics could induce phage production, the same
procedure was used as in the previous paragraph with the following
modifications. Three different antibiotic concentrations were tested
depending on the antibiotic used and bacterial strain employed. For
E. coli strains, 1, 10, and 30 mg/ml final concentrations of tobramycin
(tomycin, Orion Pharma) and 0.03, 0.3, and 3 mg/ml of ciprofloxacin
(Bayer) were used. For S. aureus strains, 1, 10, 20 mg/ml final con-
centrations of tobramycin and 1, 10, 30 mg/ml of ciprofloxacin were
used. Viable counts of cell suspensions were determined to evaluate
the antibacterial activity of UV, MitC or antibiotic treatment.
Phage purification
Phage stocks were obtained as follows. Soft agar from semi-
confluent plates was collected and mixed with LB at 3 ml per
plate, and incubated for 2 h at 37uC with aeration. Debris was
removed by centrifugation for 20 min at 8,000 rpm using a Sorvall
SS-34 rotor at 5uC. Phage particles were concentrated with 10%
polyethylene glycol 6000 and 0.5 M NaCl and were purified twice
by rate zonal centrifugation in a linear 5–20% (w/v) sucrose
gradient prepared in 20 mM Tris, pH 7.2, 1 mM MgCl2, and
0.2 mM CaCl2 [22]. Protein composition of purified virus
preparations was determined by SDS-PAGE [23].
Electron microscopy
Purified virus specimens were applied to carbon-coated grids and
were stained with 1% (w/v) potassium phosphotungstate (pH 6.5).
Micrographs were obtained with a JEOL 1200 EX electron
microscope (Institute of Biotechnology, University of Helsinki)
operated at 60 kV.
SUPPORTING INFORMATION
Table S1 Blood culture samples and original bacterial isolates
collected from the Helsinki University Hospital laboratory
Found at: doi:10.1371/journal.pone.0001145.s001 (0.12 MB
DOC)
Table S2 Characterized phage isolates
Found at: doi:10.1371/journal.pone.0001145.s002 (0.07 MB
DOC)
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